Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$55.7 - $145.79 $8.9 Million - $23.3 Million
-159,729 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$135.05 - $182.59 $4.26 Million - $5.77 Million
-31,575 Reduced 16.51%
159,729 $23.8 Million
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $764,149 - $1.01 Million
5,249 Added 2.82%
191,304 $27.9 Million
Q2 2021

Aug 11, 2021

SELL
$134.22 - $202.37 $3.42 Million - $5.16 Million
-25,486 Reduced 12.05%
186,055 $36.4 Million
Q1 2021

May 11, 2021

BUY
$140.25 - $196.86 $18.7 Million - $26.2 Million
133,326 Added 170.46%
211,541 $38.3 Million
Q4 2020

Feb 03, 2021

BUY
$126.47 - $163.7 $9.89 Million - $12.8 Million
78,215 New
78,215 $11.1 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.79B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.